Promega corporation:1107424 [15-002265] cell titer GLO solution 18EA-anton simeonov/scott martin
Ended Awarded
- Contract number
- HHSN31900005
- Awardee
-
Promega Corporation UEI MWM4N9L4S5X4
- Awarding agency
-
National Center for Advancing Translational Sciences
National Institutes of Health, Department of Health and Human Services
- Obligated
- $14,967
Award facts
- Contract value 100% obligated
- $14,967.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- Not on record
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Madison, WI 53711, USA
Award details come from SAM.gov/FPDS.
About this award
Promega Corporation received a firm fixed-price Blanket Purchase Agreement (BPA) call order valued at $14,967.00 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health. The award, issued on February 23, 2015, with completion targeted for February 28, 2015, procures CellTiter-Glo Solution in quantities of 18 units. This product order was placed under Promega's existing $10 million NIH BPA, which covers biological materials, chemicals, medical and scientific equipment, and maintenance services. The contract was not designated as a set-aside and was performed at Promega's Madison, Wisconsin facility.
CellTiter-Glo is a luciferase-based cell viability assay widely used in research settings to measure cell proliferation and cytotoxicity. As a large, for-profit life sciences manufacturer, Promega regularly supplies specialized laboratory reagents and consumables to federal agencies conducting biomedical research. NCATS, which focuses on translational science to accelerate the development of medical solutions, frequently requires high-quality research reagents and assay systems to support its screening and drug development initiatives. This call order represents routine procurement activity under Promega's established indefinite delivery vehicle with NIH.
Quick answers
Who was awarded contract HHSN31900005?
HHSN31900005 was awarded to Promega Corporation by National Center for Advancing Translational Sciences (National Institutes of Health) on February 23, 2015.
How much is contract HHSN31900005 worth?
The government has obligated $14,967 on HHSN31900005.
Is contract HHSN31900005 an order under another contract?
Yes. HHSN31900005 is a BPA call under HHSN263199900051808B, a blanket purchase agreement.
Was contract HHSN31900005 competed?
The extent of competition for HHSN31900005 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award